May 3 Preclinical Quick Takes: CRISPR, Cincinnati Children's, Chromatin

Small molecule CRISPR inhibitors are here
Two groups have reported small molecule inhibitors this week that could be used to control CRISPR-based gene editing, as the U.S. Defense Advanced Research Projects Agency

Read the full 312 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE